Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

The New England Journal of Medicine
Deepak L BhattCHARISMA Investigators

Abstract

Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been studied in a broad population of patients at high risk for atherothrombotic events. We randomly assigned 15,603 patients with either clinically evident cardiovascular disease or multiple risk factors to receive clopidogrel (75 mg per day) plus low-dose aspirin (75 to 162 mg per day) or placebo plus low-dose aspirin and followed them for a median of 28 months. The primary efficacy end point was a composite of myocardial infarction, stroke, or death from cardiovascular causes. The rate of the primary efficacy end point was 6.8 percent with clopidogrel plus aspirin and 7.3 percent with placebo plus aspirin (relative risk, 0.93; 95 percent confidence interval, 0.83 to 1.05; P=0.22). The respective rate of the principal secondary efficacy end point, which included hospitalizations for ischemic events, was 16.7 percent and 17.9 percent (relative risk, 0.92; 95 percent confidence interval, 0.86 to 0.995; P=0.04), and the rate of severe bleeding was 1.7 percent and 1.3 percent (relative risk, 1.25; 95 percent confidence interval, 0.97 to 1.61 percent; P=0.09). The rate of the primary end point among patients with multiple risk factors was 6.6 percent with clo...Continue Reading

References

Sep 2, 1993·The New England Journal of Medicine·UNKNOWN GUSTO investigators
Nov 11, 1998·Nature Medicine·A D Lopez, C C Murray
Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Nov 2, 2002·Nature Medicine·Zaverio M Ruggeri
Nov 19, 2002·JAMA : the Journal of the American Medical Association·Steven R SteinhublUNKNOWN CREDO Investigators. Clopidogrel for the Reduction of Events During Observation
Aug 17, 2004·American Heart Journal·Deepak L BhattUNKNOWN Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance Executive Committee
Mar 11, 2005·The New England Journal of Medicine·Marc S SabatineUNKNOWN CLARITY-TIMI 28 Investigators
Sep 20, 2005·Journal of the American College of Cardiology·Valentin FusterJuan J Badimon
Oct 18, 2005·Journal of the American College of Cardiology·Eric J Topol
Nov 8, 2005·Lancet·Z M ChenUNKNOWN COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group
Jan 13, 2006·JAMA : the Journal of the American Medical Association·Deepak L BhattUNKNOWN REACH Registry Investigators

❮ Previous
Next ❯

Citations

Jul 27, 2010·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·F W A Verheugt
Sep 12, 2007·Der Nervenarzt·R WeberM Grond
Jul 27, 2011·Der Nervenarzt·M EndresM Dichgans
Feb 9, 2012·European Journal of Clinical Pharmacology·Teddy KosoglouDavid L Cutler
Apr 25, 2012·European Journal of Clinical Pharmacology·Paul StatkevichDavid L Cutler
Aug 30, 2008·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·George BakrisFaiez Zannad
Jan 6, 2010·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Boris BigalkeMeinrad Gawaz
Apr 22, 2011·Journal of Neurology·Serkan OzbenTomris Ozben
Dec 31, 2011·Human Genetics·Thomas CuissetMarie-Christine Alessi
Jun 21, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Giuseppe CuriglianoMarco Colleoni
May 15, 2012·Journal of Anesthesia·Emile CalendaMarc Muraine
Oct 17, 2006·Wiener medizinische Wochenschrift·Florian B Mayr, Bernd Jilma
Dec 27, 2011·Cellular and Molecular Neurobiology·Kirtiman SrivastavaUlvi Bayraktutan
Jan 4, 2013·International Journal of Clinical Pharmacy·Yaman KassabHadeer AbdulRazzaq
Sep 30, 2006·Journal of Thrombosis and Thrombolysis·Richard C Becker
Apr 10, 2008·Journal of Thrombosis and Thrombolysis·Srinivas Iyengar, LeRoy E Rabbani
Aug 21, 2009·Journal of Thrombosis and Thrombolysis·Shepard D Weiner, LeRoy E Rabbani
May 15, 2010·Journal of Thrombosis and Thrombolysis·Martin Moser, Christoph Bode
Jun 18, 2010·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Li LiuYu Long
Jan 5, 2008·Current Atherosclerosis Reports·Graeme J Hankey
Nov 16, 2007·Current Atherosclerosis Reports·Girish R Mood, Deepak L Bhatt
May 4, 2011·Current Atherosclerosis Reports·Sharon Poisson, S Claiborne Johnston
May 24, 2007·Current Hypertension Reports·Denis L Clement, Marc L Debuyzere
Jul 16, 2009·Current Hypertension Reports·Denis L Clement
Sep 4, 2007·Current Neurology and Neuroscience Reports·William M Landau
Mar 28, 2008·Current Neurology and Neuroscience Reports·Neil E Schwartz, Gregory W Albers
Nov 26, 2010·Current Neurology and Neuroscience Reports·Thalia S Field, Oscar R Benavente
Jan 10, 2013·Current Neurology and Neuroscience Reports·Ruth M Thomson, David C Anderson
Jun 28, 2008·Current Treatment Options in Cardiovascular Medicine·Richard A Bernstein
May 13, 2009·Current Treatment Options in Cardiovascular Medicine·Michael J Schneck
Sep 16, 2010·Current Treatment Options in Cardiovascular Medicine·Carlos G Santos-GallegoJuan José Badimón
Feb 18, 2011·Current Treatment Options in Cardiovascular Medicine·Mireille Astrid Moise, Vikram S Kashyap
Apr 5, 2011·Current Treatment Options in Cardiovascular Medicine·Jaime Gállego Culleré, María Elena Erro Aguirre
Mar 23, 2013·Current Treatment Options in Cardiovascular Medicine·Marc P Bonaca, Joshua Beckman
Mar 26, 2013·Current Treatment Options in Cardiovascular Medicine·Fan Z Caprio, Shyam Prabhakaran
Mar 30, 2013·Current Treatment Options in Cardiovascular Medicine·Thalia S FieldOscar R Benavente
Jan 5, 2008·Current Treatment Options in Neurology·Neil E Schwartz, Gregory W Albers
Jan 5, 2008·Current Treatment Options in Neurology·Jeffrey A Switzer, David C Hess
Nov 7, 2009·Current Treatment Options in Neurology·Sarah Song, Bruce Ovbiagele

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.